Pancreatic Cancer Research

ResearcherOslo University HospitalActive in the last 2 years

Elin Hegland Kure

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5135-9916; OpenAlex author ID A5008647467. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 8

  1. Spatial Transcriptomics Reveals Cancer and Stromal Cell Heterogeneity Between Center and Invasive Front of Pancreatic Cancer. Co-author DOI 10.1016/j.modpat.2025.100726↗
  2. Elevated KRAS protein level is associated with better survival in pancreatic cancer. Last author DOI 10.1186/s12885-025-14461-w↗
  3. Indole 3-acetate and response to therapy in borderline resectable or locally advanced pancreatic cancer. Co-author DOI 10.3389/fonc.2024.1488749↗
  4. Meta-Analysis of 1,200 Transcriptomic Profiles Identifies a Prognostic Model for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1200/cci.18.00102↗
  5. Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2015.09.004↗
  6. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first … Co-author DOI 10.3109/0284186x.2015.1068445↗
  7. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Co-author DOI 10.1038/ncb3169↗
  8. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. Co-author DOI 10.1371/journal.pone.0103873↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Knut Jørgen Labori · 5 shared papers, 2015–2024 · strength 0.46
  2. Maia Blomhoff Holm · 1 shared paper, 2025 · strength 0.28
  3. Tine Norman Alver · 1 shared paper, 2025 · strength 0.28
  4. Caroline Sophie Verbeke · 1 shared paper, 2025 · strength 0.28
  5. Stina Margrethe Stålberg · 1 shared paper, 2025 · strength 0.27
  6. Peder R. Braadland · 1 shared paper, 2024 · strength 0.23
  7. Sheraz Yaqub · 1 shared paper, 2024 · strength 0.23
  8. Johannes R. Hov · 1 shared paper, 2024 · strength 0.23
  9. Ingvild Farnes · 1 shared paper, 2024 · strength 0.23
  10. Vandana Sandhu · 2 shared papers, 2014–2019 · strength 0.13
  11. Trond A Buanes · 2 shared papers, 2016 · strength 0.12
  12. Benjamin Haibe‐Kains · 1 shared paper, 2019 · strength 0.08
  13. Ayelet Borgida · 1 shared paper, 2019 · strength 0.08
  14. Steve Gallinger · 1 shared paper, 2019 · strength 0.08
  15. Turid Heiberg · 1 shared paper, 2016 · strength 0.06
  16. Bart M.G. Baekelandt · 1 shared paper, 2016 · strength 0.06
  17. Tom Nordby · 1 shared paper, 2016 · strength 0.06
  18. Marianne Jensen Hjermstad · 1 shared paper, 2016 · strength 0.06
  19. Matthew H. G. Katz · 1 shared paper, 2016 · strength 0.05
  20. Bjørn Edwin · 1 shared paper, 2016 · strength 0.05
  21. Svein Dueland · 1 shared paper, 2016 · strength 0.05
  22. Ivar P. Gladhaug · 1 shared paper, 2016 · strength 0.05
  23. Anna Berit Wennerström · 1 shared paper, 2014 · strength 0.05
  24. Else Munthe · 1 shared paper, 2014 · strength 0.05
  25. Jonathan Matthew Hernandez · 1 shared paper, 2015 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.